SCHEMBL24540862

SCHEMBL24540862

Cc1cccnc1CCNC(=O)[C@]1(O)C[C@H](C)CC[C@H]1C(C)C

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.40
SSTR4 P31391 1/20 0.38
ALDH1A1 P00352 3/20 0.38
HSD11B1 P28845 1/20 0.35
MEN1 O00255 1/20 0.35
MAPK1 P28482 1/20 0.35
KMT2A Q03164 1/20 0.35
KEAP1 Q14145 1/20 0.33
NFE2L2 Q16236 1/20 0.33
ADRB1 P08588 1/20 0.33
ADRB3 P13945 1/20 0.33
GPBAR1 Q8TDU6 1/20 0.33
TDP1 Q9NUW8 1/20 0.32
GRIN2B Q13224 1/20 0.32
OPRL1 P41146 1/20 0.32
TRPM8 Q7Z2W7 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
P2RX7 Q99572 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29112510 1.00 KDM4E (0.40) KDM4ESSTR4ALDH1A1HSD11B1MEN1
SCHEMBL29112514 1.00 KDM4E (0.40) KDM4ESSTR4ALDH1A1HSD11B1MEN1
SCHEMBL29112392 0.84 HSD11B1 (0.54) ALDH1A1HSD11B1MEN1KMT2ATDP1
SCHEMBL24540861 0.84 HSD11B1 (0.54) ALDH1A1HSD11B1MEN1KMT2ATDP1
SCHEMBL29112390 0.84 HSD11B1 (0.54) ALDH1A1HSD11B1MEN1KMT2ATDP1
SCHEMBL24540384 0.83 MAPT (0.41) ALDH1A1MEN1KMT2A
SCHEMBL29112427 0.83 MAPT (0.41) ALDH1A1MEN1KMT2A
SCHEMBL29681997 0.83 MAPT (0.41) ALDH1A1MEN1KMT2A
SCHEMBL24540858 0.81 HDAC2 (0.43) ALDH1A1HSD11B1MEN1KMT2ASMN1; SMN2
SCHEMBL29112296 0.81 HDAC2 (0.43) ALDH1A1HSD11B1MEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240124408-A1 Substituted Cyclohexanecarboxamides, Their Preparation and Their Therapeutic Application SANOFI (FR) 2024-04-18 US disclosed
EP-4263493-A1 SUBSTITUTED CYCLOHEXANECARBOXAMIDES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION Sanofi (FR) 2023-10-25 EP disclosed
CN-116829532-A Substituted cyclohexane carboxamides, their preparation and their therapeutic use 赛诺菲 2023-09-29 CN disclosed
WO-2022133027-A1 SUBSTITUTED CYCLOHEXANECARBOXAMIDES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION SANOFI (FR) 2022-06-23 WO disclosed
WO-2022133027-A1 SUBSTITUTED CYCLOHEXANECARBOXAMIDES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION SANOFI (FR) 2022-06-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240124408-A1 Substituted Cyclohexanecarboxamides, Their Preparation and Their Therapeutic Application TRPM8, TAS2R8, TRPM7 KDM4E 2867/4885SSTR4 456/4885ALDH1A1 3565/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.